Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor-Reference-Cited by-同舟云学术

Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor

Published:2022-02-17 Issue:4 Volume:45 Page:641-649
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Kohata Nao,Kurihara Isao,Yokota Kenichi,Kobayashi Sakiko,Murai-Takeda Ayano,Mitsuishi Yuko,Nakamura Toshifumi,Morisaki Mitsuha,Kozuma Takahide,Torimitsu Takuto,Kawai Miki,Itoh Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

https://www.nature.com/articles/s41440-022-00859-7.pdf

Reference41 articles.

1. Shibata H, Itoh H. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension. Am J Hypertens. 2012;25:514–23.

2. Morimoto S, Ichihara A. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension. Hypertens Res. 2020;43:744–53.

3. Hayashi T, Shibata H, Kurihara I, Yokota K, Mitsuishi Y, Ohashi K, et al. High glucose stimulates mineralocorticoid receptor transcriptional activity through the protein kinase C β signaling. Int Heart J. 2017;58:794–802.

4. Mitsuishi Y, Shibata H, Kurihara I, Kobayashi S, Yokota K, Murai-Takeda A, et al. Epidermal growth factor receptor/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization. Mol Cell Endocrinol. 2018;473:89–99.

5. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008;14:1370–6.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pharmacology of mineralocorticoid receptor antagonists: The role of co-regulators;Steroids;2023-11

2. Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer;Cancer Letters;2023-10

3. 2023 update and perspectives;Hypertension Research;2023-09-15

4. CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity;Hypertension Research;2022-12-16

5. Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood;International Journal of Molecular Sciences;2022-10-20